SLC3A2 and pancreatic ductal adenocarcinoma: Although this study has several limitations such as the sample size for the immunohistochemistry analysis and the lack of in vivo studies, our data provide evidence that CD98hc is upregulated in human pancreatic ductal adenocarcinoma and suggest an important role of CD98hc in malignant transformation in this disease.